ABBOTT PARK, Ill.—Abbott (NYSE: ABT) said Friday that the required waiting period under the Hart-Scott-Rodino Antitrust Act had expired on Feb. 5, leaving the way clear for its planned acquisition of Advanced Medical Optical (NYSE: EYE) to close.
In a separate announcement Friday, Advanced Medical Optics said the deal could be finalized as early as Feb. 26, after completion of that company’s tender offer on Feb. 24.
Once the acquisition is completed, Advanced Medical Optics will become a wholly owned subsidiary of Abbott.